Home » Stocks » Helius Medical Technologies

Helius Medical Technologies, Inc. (HSDT)

Stock Price: $0.535 USD -0.020 (-3.68%)
Updated Aug 3, 2020 12:46 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 20.34M
Revenue (ttm) 1.03M
Net Income (ttm) -15.86M
Shares Out 38.04M
EPS (ttm) -0.57
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 3, 2020
Last Price $0.535
Previous Close $0.555
Change ($) -0.020
Change (%) -3.68%
Day's Open 0.540
Day's Range 0.524 - 0.560
Day's Volume 223,025
52-Week Range 0.249 - 2.350

More Stats

Market Cap 20.34M
Enterprise Value 16.57M
Earnings Date (est) Aug 6, 2020
Ex-Dividend Date n/a
Shares Outstanding 38.04M
Float 30.92M
EPS (basic) -0.58
EPS (diluted) -0.57
FCF / Share -0.59
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 940,522
Short Ratio 1.49
Short % of Float 3.10%
Beta 0.94
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 19.82
PB Ratio 3.96
Revenue 1.03M
Operating Income -21.18M
Net Income -15.86M
Free Cash Flow -18.15M
Net Cash 3.76M
Net Cash / Share 0.10
Gross Margin 63.35%
Operating Margin -2,064.04%
Profit Margin -1,544.50%
FCF Margin -1,769.20%
ROA -84.40%
ROE -184.15%
ROIC -4,766.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 0
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Hold

Price Target

$10.00*
Low
10.0
Current: $0.535
High
10.0
Target: 10.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201520142013
Revenue1.500.48----
Revenue Growth212.97%-----
Gross Profit0.650.48----
Operating Income-24.00-26.68-22.85-9.32-9.81-1.07
Net Income-9.78-28.62-28.02-6.88-9.84-1.07
Shares Outstanding26.3522.7918.6313.3011.416.41
Earnings Per Share-0.37-1.26-1.50-0.60-0.85-0.15
Operating Cash Flow-21.00-19.62-19.33-7.94-6.32-0.35
Capital Expenditures-0.35-0.44-0.19---
Free Cash Flow-21.35-20.06-19.52-7.94-6.32-0.35
Cash & Equivalents5.4625.585.562.640.800.02
Total Debt0.64----0.37
Net Cash / Debt4.8225.585.562.640.80-0.35
Assets10.3527.836.814.041.220.32
Liabilities4.5117.9714.304.062.780.58
Book Value5.849.85-7.49-0.02-1.56-0.27
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Helius Medical Technologies, Inc.
Country United States
Employees 19
CEO Philippe Deschamps

Stock Information

Ticker Symbol HSDT
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: HSDT

Description

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.